These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


618 related items for PubMed ID: 10616090

  • 1. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
    Pluta RM, Afshar JK, Thompson BG, Boock RJ, Harvey-White J, Oldfield EH.
    J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
    [Abstract] [Full Text] [Related]

  • 2. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
    Pluta RM, Oldfield EH, Boock RJ.
    J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
    [Abstract] [Full Text] [Related]

  • 3. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.
    Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH.
    J Neurosurg; 1995 Jul; 83(1):118-22. PubMed ID: 7782826
    [Abstract] [Full Text] [Related]

  • 4. Intracisternal versus intracarotid infusion of L-arginine in experimental cerebral vasospasm.
    Ozüm U, Aslan A, Karadağ O, Gürelik M, Taş A, Zafer Kars H.
    J Clin Neurosci; 2007 Jun; 14(6):556-62. PubMed ID: 17430779
    [Abstract] [Full Text] [Related]

  • 5. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH.
    JAMA; 2005 Mar 23; 293(12):1477-84. PubMed ID: 15784871
    [Abstract] [Full Text] [Related]

  • 6. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM.
    J Neurosurg; 2004 Nov 23; 101(5):836-42. PubMed ID: 15543672
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endothelial dysfunction in a primate model of cerebral vasospasm.
    Iuliano BA, Pluta RM, Jung C, Oldfield EH.
    J Neurosurg; 2004 Feb 23; 100(2):287-94. PubMed ID: 15086237
    [Abstract] [Full Text] [Related]

  • 9. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Jung CS, Oldfield EH, Harvey-White J, Espey MG, Zimmermann M, Seifert V, Pluta RM.
    J Neurosurg; 2007 Nov 23; 107(5):945-50. PubMed ID: 17977265
    [Abstract] [Full Text] [Related]

  • 10. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates.
    Clatterbuck RE, Gailloud P, Ogata L, Gebremariam A, Dietsch GN, Murphy KJ, Tamargo RJ.
    J Neurosurg; 2003 Aug 23; 99(2):376-82. PubMed ID: 12924713
    [Abstract] [Full Text] [Related]

  • 11. Intracarotid L-arginine reverses motor evoked potential changes in experimental cerebral vasospasm.
    Ozüm U, Aslan A, Taş A, Kars HZ.
    Turk Neurosurg; 2007 Aug 23; 17(1):13-8. PubMed ID: 17918672
    [Abstract] [Full Text] [Related]

  • 12. Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot.
    Zhang ZD, Yamini B, Komuro T, Ono S, Johns L, Marton LS, Weir B, Macdonald RL.
    Stroke; 2001 Aug 23; 32(8):1868-74. PubMed ID: 11486119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm.
    Aihara Y, Jahromi BS, Yassari R, Sayama T, Macdonald RL.
    Neurosurgery; 2003 Mar 23; 52(3):661-7; discussion 666-7. PubMed ID: 12590692
    [Abstract] [Full Text] [Related]

  • 15. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage.
    Horky LL, Pluta RM, Boock RJ, Oldfield EH.
    J Neurosurg; 1998 Feb 23; 88(2):298-303. PubMed ID: 9452239
    [Abstract] [Full Text] [Related]

  • 16. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.
    Pluta RM.
    Neurol Res; 2006 Oct 23; 28(7):730-7. PubMed ID: 17164036
    [Abstract] [Full Text] [Related]

  • 17. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage.
    Pluta RM, Afshar JK, Boock RJ, Oldfield EH.
    J Neurosurg; 1998 Mar 23; 88(3):557-61. PubMed ID: 9488312
    [Abstract] [Full Text] [Related]

  • 18. The therapeutic effect of continuous intracisternal L-Arginine infusion on experimental cerebral vasospasm.
    Göksel HM, Ozüm U, Oztoprak I.
    Acta Neurochir (Wien); 2001 Mar 23; 143(3):277-85. PubMed ID: 11460916
    [Abstract] [Full Text] [Related]

  • 19. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage.
    Takahashi M, Zhang ZD, Macdonald RL.
    J Neurosurg; 2011 Apr 23; 114(4):1104-9. PubMed ID: 20597600
    [Abstract] [Full Text] [Related]

  • 20. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm.
    Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH.
    J Neurosurg; 1996 Apr 23; 84(4):648-54. PubMed ID: 8613858
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.